Sanui Ayako

サヌイアヤコ | Sanui Ayako

Affiliation and department：
Papers (5)：

MIYAMOTO Shingo, KURAKAZU Masamitsu, YOTSUMOTO Fusanori, ARIMA Hisatomi, IZUCHI Daisuke, URUSHIYAMA Daichi, MIYATA Kohei, KIYOSHIMA Chihiro, FUKAGAWA Satoshi, YOSHIKAWA Ken-Ichi, et al. The combination of maternal blood and amniotic fluid biomarkers improves the predictive accuracy of histologic chorioamnionitis. Placenta. 2019. 80. 4-7
MIYAMOTO Shingo, IZUCHI Daisuke, FUKAGAWA Satoshi, YOTSUMOTO Fusanori, YOSHIKAWA Ken-Ichi, KIYOSHIMA Chihiro, NAN Son-U, MIYATA Kohei, ITO Tomohiro, KURAKAZU Masamitsu, et al. Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer. Anticancer Res. 2018. 38. 7. 4347-4351
MIYAMOTO Shingo, ARAKI Ryota, KIYOSHIMA Chihiro, KURAKAZU Masamitsu, SANUI Ayako, YOTSUMOTO Fusanori, MURATA Masaharu. Microbiome profile of the amniotic fluid as a predictive biomarker of perinatal outcome. Scientific Report. 2017
Kohei Miyata, Fusanori Yotsumoto, Satoshi Fukagawa, Chihiro Kiyoshima, Nam Sung Ouk, Daichi Urushiyama, Tomohiro Ito, Takahiro Katsuda, Masamitsu Kurakazu, Ryota Araki, et al. Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer. ANTICANCER RESEARCH. 2017. 37. 7. 3955-3960
MIYAMOTO Shingo, YOTSUMOTO Fusanori, SANUI Ayako. BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study. BMC Cancer. 2017. 17

Professional career (1)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page